Evidence map›Paper›PMID 21673813›Full record

ArticlePloS one2011

Beta-carotene reduces body adiposity of mice via BCMO1.

Jaume Amengual, Erwan Gouranton, Yvonne G J van Helden, Susanne Hessel, Joan Ribot, Evelien Kramer, Beata Kiec-Wilk, Ursula Razny, Georg Lietz, Adrian Wyss and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 160 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Recent advances in carotenoid absorption, distribution, and elimination.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Immunometabolic effects ofImmunometabolism (Cobham, Surrey) · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. β-carotene accelerates the resolution of atherosclerosis in mice.bioRxiv : the preprint server for biology · 2024
    Article
  16. Carotenoids in Health as Studied by Omics-Related Endpoints.Advances in nutrition (Bethesda, Md.) · 2023
    Review
  17. Article
  18. Article
  19. Macauba (Nutrients · 2023
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 8 countries.

Jaume AmengualLaboratory of Molecular Biology, Nutrition and Biotechnology, Universitat de les Illes Balears and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Palma de Mallorca, Spain.
Erwan Gouranton
Yvonne G J van Helden
Susanne Hessel
Joan Ribot
Evelien Kramer
Beata Kiec-Wilk
Ursula Razny
Georg Lietz
Adrian Wyss
Aldona Dembinska-Kiec
Andreu Palou
Jaap Keijer
Jean François Landrier
M Luisa Bonet
Johannes von Lintig
Aix-Marseille Université · FRJagiellonian University · PLSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESWageningen University & Research · NLCase Western Reserve University · USCentro de Investigación Biomédica en Red · ESDSM (Netherlands) · NLNewcastle University · GBUniversitat de les Illes Balears · ESUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence from cell culture studies indicates that β-carotene-(BC)-derived apocarotenoid signaling molecules can modulate the activities of nuclear receptors that regulate many aspects of adipocyte physiology. Two BC metabolizing enzymes, the BC-15,15'-oxygenase (Bcmo1) and the BC-9',10'-oxygenase (Bcdo2) are expressed in adipocytes. Bcmo1 catalyzes the conversion of BC into retinaldehyde and Bcdo2 into β-10'-apocarotenal and β-ionone. Here we analyzed the impact of BC on body adiposity of mice. To genetically dissect the roles of Bcmo1 and Bcdo2 in this process, we used wild-type and Bcmo1(-/-) mice for this study. In wild-type mice, BC was converted into retinoids. In contrast, Bcmo1(-/-) mice showed increased expression of Bcdo2 in adipocytes and β-10'-apocarotenol accumulated as the major BC derivative. In wild-type mice, BC significantly reduced body adiposity (by 28%), leptinemia and adipocyte size. Genome wide microarray analysis of inguinal white adipose tissue revealed a generalized decrease of mRNA expression of peroxisome proliferator-activated receptor γ (PPARγ) target genes. Consistently, the expression of this key transcription factor for lipogenesis was significantly reduced both on the mRNA and protein levels. Despite β-10'-apocarotenoid production, this effect of BC was absent in Bcmo1(-/-) mice, demonstrating that it was dependent on the Bcmo1-mediated production of retinoids. Our study evidences an important role of BC for the control of body adiposity in mice and identifies Bcmo1 as critical molecular player for the regulation of PPARγ activity in adipocytes.

Indexed as

Adipocytes, WhiteAdiposityAnimalsbeta Carotenebeta-Carotene 15,15'-MonooxygenaseDietary SupplementsDioxygenasesDown-RegulationFemaleMiceMice, Inbred C57BLOxygenasesPPAR gammaRetinoidsBco1 protein, mouseBco2 protein, mousebeta Carotenebeta-Carotene 15,15'-MonooxygenaseDioxygenasesOxygenasesPPAR gammaRetinoids

Identifiers

PMID21673813
PMCPMC3106009
OpenAlexW1989658935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.